期刊文献+

盐酸普拉克索的合成工艺改进 被引量:4

Process Improvement on the Synthesis of Pramipexole Hydrochloride
在线阅读 下载PDF
导出
摘要 以(S)-2,6-二氨基-4,5,6,7-四氢苯并噻唑(3)为原料,经缩合、还原反应制得普拉克索(2);2与盐酸成盐后制得盐酸普拉克索一水合物(1),其结构经1H NMR,13C NMR,IR和MS(ESI)确证。研究了溶剂、反应温度、投料比γ[n(3)∶n(正丙醛)]、析晶终止温度和精制降温速度对1收率的影响。结果表明:在最佳反应条件(无水甲醇为溶剂,γ=1.0∶1.8,于-15^-20℃反应,析晶终止温度为-5^-10℃)下,最高收率可达61.5%。 Pramipexole(2) was prapared from(S)-2,6-diamino-4,5,6,7-tetrahydro-benzothiazole(3)by condensation and reduction reaction. Pramipexole hydrochloride(1) was synthesized from 2 via salification and drecrystallization. The structure was confirmed by1 H NMR,13 C NMR,IR and MS(ESI). The effect of reaction solvent,reaction temperature,the raw ratio γ[n(3) ∶ n(n-propionaldehyde) ] and terminational temperature of crystallization and cooling speed of refining on the yield of 1were invistigated. The yield was up to 61. 5% under the optimized conditons(anhydrous methanol as reaction solvent,γ = 1. 0∶ 1. 8,reaction at-15 --20 ℃,terminational temperature of crystallization was-5 --10 ℃).
作者 黄斌 李景 何作瑜 谢银彩 王诗红 HUANG Bin LI Jing HE Zuo-yu XIE Yin-cai WANG Shi-hong(The Fifth Affiliated(Zhuhai) Hospital, Zunyi Medical College, Zhuhai 519100, China)
出处 《合成化学》 CAS CSCD 2017年第3期261-264,共4页 Chinese Journal of Synthetic Chemistry
基金 贵州省科学技术基金资助项目(黔科合LH字[2014]7560号)
关键词 (S)-2 6-二氨基-4 5 6 7-四氢苯并噻唑 盐酸普拉克索 抗帕金森氏病药 药物合成 工艺改进 (S)-2 6-diamino-4 5 6 7-tetrahydro-benzothiazol pramipexole hydrochloride anti-Parkinson's disease drug drug synthesis process improvement
  • 相关文献

参考文献5

二级参考文献79

  • 1郑琼,尹先清.一步法合成6-乙酰氨基-2-氨基-4,5,6,7-四氢苯并噻唑[J].化学工程师,2006,20(3):57-58. 被引量:2
  • 2李新发,傅相锴.THAM衍生席夫碱的合成、表征及互变异构平衡研究[J].西南师范大学学报(自然科学版),2006,31(4):97-100. 被引量:2
  • 3曾丽莉,陈生弟.普拉克索在帕金森病治疗中的临床应用[J].中国现代神经疾病杂志,2007,7(1):44-47. 被引量:7
  • 4武力勇,贾建平.普拉克索的临床应用及安全性[J].药物不良反应杂志,2007,9(2):77-80. 被引量:20
  • 5Treatment of central nervous system degenerative disorders:Parkinson's disease.In:Brunton LL,Blumenthal D,Buxtun I,et al.Goodman's manual of pharmacology and therapeutics[M].NY:Mc Graw-Hill Professional,2007.
  • 6Rascal O,Goetz C,Koller W,et al.Treatment interventions for Parkinson's disease.An evidence based assessment[J].Lancet,2002,359(9317):1589-1598.
  • 7Lees A.Alternatives to levodopa in the initial treatment of early Parkinson's disease[J].Drugs Aging,2005,22(9):731-740.
  • 8Lees AJ.Drugs for Parkinson's disease[J].J Neurol Neurosurg Psychiatry,2002,73(6):607-610.
  • 9Miyasaki JM,Martin W,Suchowersky O,et al.Practive parameter:initiation of treatment for Parkinson's disease:an evidence-based review:report of Quality Standards Subcommittee of the American Academy of Neurology[J].Neurology,2002,58(1):11-17.
  • 10Koda-Kimble MA,Young LY,Aldredge BK,et al.Applied therapeutics.The Clinical Use of Drugs 9th ed.San Francisco[M].Calif:Lippincott Willians & Wikins,2008.

共引文献29

同被引文献24

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部